HomeMDGL • NASDAQ
Madrigal Pharmaceuticals Inc
Follow
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 287.27M | 362.03% |
Operating expense | 383.12M | 117.28% |
Net income | -114.19M | -6.76% |
Net profit margin | -39.75 | 76.89% |
Earnings per share | -4.96 | -0.72% |
EBITDA | -113.62M | 2.06% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.11B | 11.13% |
Total assets | 1.36B | 26.95% |
Total liabilities | 736.73M | 148.80% |
Total equity | 625.73M | — |
Shares outstanding | 22.71M | — |
Price to book | 20.28 | — |
Return on assets | -23.97% | — |
Return on capital | -31.80% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -114.19M | -6.76% |
Cash from operations | 79.85M | 219.21% |
Cash from investing | -207.00M | -2.28% |
Cash from financing | 236.65M | 3,071.36% |
Net change in cash | 109.50M | 141.81% |
Free cash flow | 113.01M | 415.38% |
Previous close
$558.99
Day range
$553.24 - $570.24
Year range
$265.00 - $577.90
Market cap
12.71B USD
Avg Volume
375.49K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2011
Headquarters
Website
Employees
528
